Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China.

Haizhu ChenYan QinJianliang YangPeng LiuXiaohui HeShengyu ZhouChanggong ZhangSheng YangLin GuiYan SunYuan-Kai Shi

Published in: Asia-Pacific journal of clinical oncology (2021)

The outcome of adult patients with relapsed or refractory T-LBL is extremely dismal. Patients with relapsed or refractory T-LBL should be encouraged to participate in clinical trials where novel therapeutic approaches are available.

Keyphrases

diffuse large b cell lymphoma
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
multiple myeloma
clinical trial